Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
出版年份 2015 全文链接
标题
Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
作者
关键词
-
出版物
HEPATOLOGY
Volume 62, Issue 2, Pages 627-634
出版商
Wiley
发表日期
2015-01-28
DOI
10.1002/hep.27720
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions
- (2014) Mina Kabiri et al. ANNALS OF INTERNAL MEDICINE
- Accelerating Drug Development Through Collaboration: The Hepatitis C Drug Development Advisory Group
- (2014) C Hutchison et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Accelerated Access to Innovative Medicines for Patients in Need
- (2014) L G Baird et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Synthesis and functional characterization of a fluorescent peptide probe for non invasive imaging of collagen in live tissues
- (2014) Ushasri Chilakamarthi et al. EXPERIMENTAL CELL RESEARCH
- Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
- (2014) Shuhei Yoshida et al. GASTROENTEROLOGY
- Integrins, myofibroblasts, and organ fibrosis
- (2014) Michel Fausther et al. HEPATOLOGY
- Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury
- (2014) Ingrid Lua et al. HEPATOLOGY
- Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+macrophage infiltration in mice
- (2014) Christer Baeck et al. HEPATOLOGY
- The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis
- (2014) Michael H Miller et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Origin of myofibroblasts in the fibrotic liver in mice
- (2014) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies
- (2014) Jun Xu et al. Frontiers in Pharmacology
- Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
- (2013) Sunder Mudaliar et al. GASTROENTEROLOGY
- Elastin-based molecular MRI of liver fibrosis
- (2013) Josef Ehling et al. HEPATOLOGY
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
- (2013) Jean-Philippe Pradere et al. HEPATOLOGY
- Evolving therapies for liver fibrosis
- (2013) Detlef Schuppan et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular MRI of collagen to diagnose and stage liver fibrosis
- (2013) Bryan C. Fuchs et al. JOURNAL OF HEPATOLOGY
- Role of magnetic resonance elastography in compensated and decompensated liver disease
- (2013) Sumeet K. Asrani et al. JOURNAL OF HEPATOLOGY
- Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
- (2013) Neil C Henderson et al. NATURE MEDICINE
- Convergent pathways that cause hepatic fibrosis in NASH
- (2013) Scott L. Friedman Nature Reviews Gastroenterology & Hepatology
- The Gordian Knot of dysbiosis, obesity and NAFLD
- (2013) Wajahat Z. Mehal Nature Reviews Gastroenterology & Hepatology
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Peripheral Cannabinoid-1 Receptor Inverse Agonism Reduces Obesity by Reversing Leptin Resistance
- (2012) Joseph Tam et al. Cell Metabolism
- TGF-β signaling in tissue fibrosis: Redox controls, target genes and therapeutic opportunities
- (2012) Rohan Samarakoon et al. CELLULAR SIGNALLING
- Mechanisms of Disease Progression in NASH
- (2012) Brittany N. Bohinc et al. Clinics in Liver Disease
- Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo
- (2012) Joy X. Jiang et al. FREE RADICAL BIOLOGY AND MEDICINE
- Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
- (2012) Laurent Castera GASTROENTEROLOGY
- Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
- (2012) Fanli Meng et al. GASTROENTEROLOGY
- Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent
- (2012) Tomonori Aoyama et al. HEPATOLOGY
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Anti-fibrotic therapy: Lost in translation?
- (2012) Detlef Schuppan et al. JOURNAL OF HEPATOLOGY
- Functional aspects on the pathophysiology of portal hypertension in cirrhosis
- (2012) Juan-Carlos García-Pagán et al. JOURNAL OF HEPATOLOGY
- Microparticles: Modulators and biomarkers of liver disease
- (2012) Miroslaw Kornek et al. JOURNAL OF HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease
- (2012) Thomas A Wynn et al. NATURE MEDICINE
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
- (2012) T. Kisseleva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Acoustic Radiation Force on the Binding Efficiency of BR55, a VEGFR2-Specific Ultrasound Contrast Agent
- (2012) Peter J.A. Frinking et al. ULTRASOUND IN MEDICINE AND BIOLOGY
- Liver stiffness diminishes with antiviral response in chronic hepatitis C
- (2011) C. Hézode et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatic stellate cells require a stiff environment for myofibroblastic differentiation
- (2011) Abby L. Olsen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts
- (2011) Antonio Mazzocca et al. HEPATOLOGY
- Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?
- (2011) Indra Neil Guha et al. HEPATOLOGY
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice
- (2011) Yong-Han Paik et al. HEPATOLOGY
- Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice
- (2011) Ruchi Bansal et al. HEPATOLOGY
- Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
- (2011) Cynthia D. Guy et al. HEPATOLOGY
- Quantitative histological-hemodynamic correlations in cirrhosis
- (2011) Supatsri Sethasine et al. HEPATOLOGY
- Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial
- (2011) Gregory T. Everson et al. HEPATOLOGY
- Scraping fibrosis: Expressway to the core of fibrosis
- (2011) Wajahat Z Mehal et al. NATURE MEDICINE
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelin and hepatic wound healing
- (2011) Al-karim Khimji et al. PHARMACOLOGICAL RESEARCH
- Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man
- (2010) J.M. Schattenberg et al. DIGESTIVE DISEASES
- Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo
- (2010) Joy X. Jiang et al. GASTROENTEROLOGY
- Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
- (2010) R. J. Fontana et al. GUT
- Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
- (2010) J. Parkes et al. GUT
- Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C
- (2010) Paul Calès et al. LIVER INTERNATIONAL
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- Portal fibroblasts: Underappreciated mediators of biliary fibrosis
- (2009) Jonathan A. Dranoff et al. HEPATOLOGY
- Targeting liver fibrosis: Strategies for development and validation of antifibrotic therapies
- (2009) Yury Popov et al. HEPATOLOGY
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update
- (2008) T. Poynard et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression
- (2008) Eleonora Patsenker et al. GASTROENTEROLOGY
- Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
- (2008) Marlyn J. Mayo et al. HEPATOLOGY
- Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
- (2008) Marc Mejias et al. HEPATOLOGY
- Exceeding the limits of liver histology markers
- (2008) Shruti H. Mehta et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search